GONADOTROPIN-RELEASING HORMONE AGONIST

Clinical trials for GONADOTROPIN-RELEASING HORMONE AGONIST explained in plain language.

Never miss a new study

Get alerted when new GONADOTROPIN-RELEASING HORMONE AGONIST trials appear

Sign up with your email to follow new studies for GONADOTROPIN-RELEASING HORMONE AGONIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

A simple blood test may reveal hidden infertility risk in young cancer survivors

Knowledge-focused Recruiting now

This study investigates whether a blood marker called anti-Müllerian hormone (AMH) can predict future infertility in children and adolescents who have undergone cancer treatment. Many young patients recover normal menstrual cycles or puberty after chemotherapy, but their ovarian …

Matched conditions: GONADOTROPIN-RELEASING HORMONE AGONIST

Sponsor: Erasme University Hospital • Aim: Knowledge-focused

Last updated Aug 14, 2026 00:00 UTC

GONADOTROPIN-RELEASING HORMONE AGONIST

Get alerted when new GONADOTROPIN-RELEASING HORMONE AGONIST trials appear

A simple blood test may reveal hidden infertility risk in young cancer survivors